Home Insights Assessing the commercial potential of an asset in Tourette’s Syndrome

Assessing the commercial potential of an asset in Tourette’s Syndrome

Less than 1 min read
Scroll

SmartAnalyst was set the task to evaluate the commercial opportunity for a potential asset in Tourette’s Syndrome.

SmartAnalyst conducted both primary and secondary research to develop a future disease landscape, a Target Product Profile (TPP) and revenue forecast.

SmartAnalyst demonstrated the potential of the asset through  scenario evaluation and the impact on revenue and valuation..

Read the full case study here.